Takashi Ishizaki - Publications, H-index & Citations

Takashi Ishizaki

Oita University

57H指数

419论文数

1.2W被引数

收录论文 40

发表时间

Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

IF7.4

2009-08-04

PREAI

Haraoka, K; Ando, Y; Ando, E; Sun, XG; Nakamura, M; Terazaki, H; Misumi, S; Tanoue, Y; Tajiri, T; Shoji, S; Ishizaki, T; Okabe, H; Tanihara, H

Analysis of glutamate homeostasis by overexpression of Fd-GOGAT gene in Arabidopsis thaliana 拟南芥fd-gogat基因过表达对谷氨酸稳态的分析

AMINO ACIDS

IF2.4

2009-05-26

PREAI

Ishizaki, Takashi; Ohsumi, Chieko; Totsuka, Kazuhiko; Igarashi, Daisuke

MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese

LIFE SCIENCES

IF5.1

2008-08-01

PREAI

Sugimoto, Mitsushige; Furuta, Takahisa; Shirai, Naohito; Kodaira, Chise; Nishino, Masafumi; Yamade, Mihoko; Ikuma, Mutsuhiro; Sugimura, Haruhiko; Ishizaki, Takashi; Hishida, Akira

Maintenance time of sedative effects after an intravenous infusion of diazepam: A guide for endoscopy using diazepam

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2008-01-01

OAAI

Sugimoto, Mitsushige; Furuta, Takahisa; Nakamura, Akiko; Shirai, Naohito; Ikuma, Mutsuhiro; Misaka, Shingen; Uchida, Shinya; Watanabe, Hiroshi; Ohashi, Kyoichi; Ishizaki, Takashi; Hishida, Akira

Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP2C19 genotypes and 23S rRNA genotypes of H-pylori

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2007-06-15

OAAI

Furuta, T.; Sugimoto, M.; Shirai, N.; Matsushita, F.; Nakajima, H.; Kumagai, J.; Senoo, K.; Kodaira, C.; Nishino, M.; Yamade, M.; Ikuma, M.; Watanabe, H.; Umemura, K.; Ishizaki, T.; Hishida, A.

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H-pylori

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2007-01-10

156

PREAI

Furuta, T.; Shirai, N.; Kodaira, M.; Sugimoto, M.; Nogaki, A.; Kuriyama, S.; Iwaizumi, M.; Yamade, M.; Terakawa, I.; Ohashi, K.; Ishizaki, T.; Hishida, A.

Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P4502CI9 genotype status

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2006-11-01

PREAI

Sugimoto, Mitsushige; Furuta, Takahisa; Shirai, Naohito; Ikuma, Mutsuhiro; Hishida, Akira; Ishizaki, Takashi

Sumoylation of a meiosis-specific RecA homolog, Lim15/Dmc1, via interaction with the small ubiquitin-related modifier (SUMO)-conjugating enzyme Ubc9

FEBS JOURNAL

IF4.2

2006-07-31

OAAI

Koshiyama, Akiyo; Hamada, Fumika N.; Namekawa, Satoshi H.; Iwabata, Kazuki; Sugawara, Hiroko; Sakamoto, Aiko; Ishizaki, Takashi; Sakaguchi, Kengo

Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2006-07-01

PREAI

Sugimoto, Mitsushige; Furuta, Takahisa; Shirai, Naohito; Ikuma, Mutsuhiro; Hishida, Akira; Ishizaki, Takashi

Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2005-10-21

PREAI

Sugimoto, M; Furuta, T; Shirai, N; Nakamura, A; Kajimura, M; Sugimura, H; Hishida, A; Ishizaki, T

Comparison of an increased dosage regimen of rabcprazolc versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P4502C19 genotypes

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2005-04-01

PREAI

Sugimoto, M; Furuta, T; Shirai, N; Nakamura, A; Kajimura, M; Hishida, A; Ohashi, K; Ishizaki, T

The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2005-01-20

OAAI

Hombhanje, FW; Hwaihwanje, I; Tsukahara, T; Saruwatari, J; Nakagawa, M; Osawa, H; Paniu, MM; Takahashi, N; Lum, JK; Aumora, B; Masta, A; Sapuri, M; Kobayakawa, T; Kaneko, A; Ishizaki, T

Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension

LIFE SCIENCES

IF5.1

2004-12-01

PREAI

Watanabe, H; Kosuge, K; Nishio, S; Yamada, H; Uchida, S; Satoh, H; Hayashi, H; Ishizaki, T; Ohashi, K

Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2004-10-01

113

OAAI

Sugimoto, M; Furuta, T; Shirai, N; Kajimura, M; Hishida, A; Sakurai, M; Ohashi, K; Ishizaki, T

The use of urine to clarify the genotype of a patient with toxic phenytoin concentrations who had undergone peripheral blood stem cell transplantation

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2004-06-04

OAAI

Ariyoshi, N; Sho-no, K; Nishimura, M; Ito, M; Nakamura, H; Asai, T; Saitoh, Y; Ishizaki, T; Kitada, M

Polymorphism of Interleukin-1β Affects the Eradication Rates of Helicobacter pylori by Triple Therapy

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2004-01-01

PREAI

Furuta, Takahisa; Shirai, Naohito; Xiao, Fang; El-omar, Emad M.; Rabkin, Charles S.; Sugimura, Haruhiko; Ishizaki, Takashi; Ohashi, Kyoichi

A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo

LABORATORY INVESTIGATION

IF4.2

2003-12-01

PREAI

Ando, Y; Haraoka, K; Terazaki, H; Tanoue, Y; Ishikawa, K; Katsuragi, S; Nakamura, M; Sun, XG; Nakagawa, K; Sasamoto, K; Takesako, K; Ishizaki, T; Sasaki, Y; Doh-ura, K

Retreatment of H-pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2003-11-20

PREAI

Furuta, T; Shirai, N; Sugimoto, M; Ohashi, K; Ishizaki, T

Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2003-11-07

OAAI

Kobayashi, K; Nakajima, M; Chiba, K; Yamamoto, T; Tani, M; Ishizaki, T; Kuroiwa, Y